Joachim Ngiam1, Hee-Moon Kyung. 1. Department of Orthodontics, School of Dentistry, Kyungpook National University, Daegu, Korea.
Abstract
OBJECTIVE: To investigate the efficacy of orthodontic microimplant-based mandibular advancement therapies for the treatment of snoring and obstructive sleep apnea (OSA) in adult patients. MATERIALS AND METHODS: Ten adult OSA patients (seven men, three women; mean age 60.00 ± 9.25 years) were each treated with two mandibular orthodontic microimplants attached to a customized reverse face mask for mandibular advancement. Pretreatment and posttreatment outcome measures of microimplant mobility, apnea-hypopnea index, snoring, respiratory movement, and Epworth sleepiness scores were evaluated after 6 months. RESULTS: Highly significant reductions in the apnea-hypopnea index, snoring, and sleep variables were observed. Sixteen of the 20 (80%) microimplants were stable and showed no mobility, and four (20%) demonstrated grade 1 or 2 mobility and required removal and reinsertion of a new microimplant. CONCLUSIONS: Favorable reductions in sleep variables highlight the potential of microimplant-based mandibular advancement therapy as an alternative treatment modality for OSA patients who cannot tolerate continuous positive airway pressure and oral appliance therapy.
OBJECTIVE: To investigate the efficacy of orthodontic microimplant-based mandibular advancement therapies for the treatment of snoring and obstructive sleep apnea (OSA) in adult patients. MATERIALS AND METHODS: Ten adult OSA patients (seven men, three women; mean age 60.00 ± 9.25 years) were each treated with two mandibular orthodontic microimplants attached to a customized reverse face mask for mandibular advancement. Pretreatment and posttreatment outcome measures of microimplant mobility, apnea-hypopnea index, snoring, respiratory movement, and Epworth sleepiness scores were evaluated after 6 months. RESULTS: Highly significant reductions in the apnea-hypopnea index, snoring, and sleep variables were observed. Sixteen of the 20 (80%) microimplants were stable and showed no mobility, and four (20%) demonstrated grade 1 or 2 mobility and required removal and reinsertion of a new microimplant. CONCLUSIONS: Favorable reductions in sleep variables highlight the potential of microimplant-based mandibular advancement therapy as an alternative treatment modality for OSA patients who cannot tolerate continuous positive airway pressure and oral appliance therapy.
Authors: Anh Tu Duy Nguyen; Vincent Jobin; Richard Payne; Josée Beauregard; Naftaly Naor; R John Kimoff Journal: Sleep Date: 2005-05 Impact factor: 5.849
Authors: Sharon A Lee; Terence C Amis; Karen Byth; George Larcos; Kristina Kairaitis; Tracey D Robinson; John R Wheatley Journal: Sleep Date: 2008-09 Impact factor: 5.849
Authors: Felix de Carlos; Juan Cobo; Maria Pilar Fernandez Mondragon; Alberto Alvarez Suarez; Juan Calvo Blanco Journal: Sleep Breath Date: 2009-09-18 Impact factor: 2.816
Authors: Terri E Weaver; Michael W Calik; Sarah S Farabi; Anne M Fink; Maria T Galang-Boquiren; Mary C Kapella; Bharati Prasad; David W Carley Journal: Nat Sci Sleep Date: 2014-11-18